MACK

Merrimack Pharmaceuticals, Inc.

Delisted

MACK was delisted on the 17th of May, 2024.

67 hedge funds and large institutions have $126M invested in Merrimack Pharmaceuticals, Inc. in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.67M
Puts
$2.07M
Net Calls
Net Calls Change

Top Buyers

1 +$3.73M
2 +$1.69M
3 +$1.16M
4
BlackRock
BlackRock
New York
+$708K
5
Renaissance Technologies
Renaissance Technologies
New York
+$656K

Top Sellers

1 -$2.32M
2 -$1.02M
3 -$637K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$176K
5
FLC
Fifth Lane Capital
Texas
-$134K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$13.1K
52
$11.6K
53
$7.79K
54
$6.71K
55
$4.02K
56
$4.02K
57
$4.02K
58
$3.64K
59
$3.17K
60
$2K
61
$1.14K
62
$1K
63
$1K
64
$604
65
$201
66
$107
67
$27
68
69
70
71
72
73
74